Skip to main content
SpringerLink
Log in

An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

The aim of this research was to determine whether an intensive, nurse-led clinic could achieve recommended vascular risk reduction targets in patients with type 2 diabetes as compared to standard diabetes management.

Method

Two hundred patients with type 2 diabetes were recruited to receive either intensive nurse-led or standard diabetes care in a 1-year open study.

Results

In each group 94 patients completed the study. The groups were matched for age and baseline HbA1c, blood pressure and lipid profiles. More patients in the intensive group achieved vascular risk targets than in the standard group: SBP (<130 mmHg) 33 versus 12.1%, (P < 0.001); DBP (<80 mmHg) 75.5 versus 40.2%, (P < 0.001); cholesterol (<4.8 mmol/L) 84.8 versus 63.6% (P = 0.003); LDL (<2.6 mmol/L) 73.4 versus 54.5% (P = 0.007); HbA1c (<6.5%) 53.2 versus 32.9% (P = 0.005).

Conclusion

An intensive nurse-led clinic is more successful in achieving vascular risk targets than standard diabetes care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. International Diabetes Foundation (2003) Diabetes atlas, 2nd edn.  Executive summary. International Diabetes Foundation, Brussels, p 8

  2. World Health Organisation (2007) Prevalence of diabetes in the WHO European region. http://www.who.int/diabetes/facts/world_figures/en/index4.htm. Accessed 21 Nov 2007

  3. Institute of Public Health in Ireland (2006) Making diabetes count, a systematic approach to estimating population prevalence on the island of Ireland in 2005. First report of the Irish Diabetes Prevalence Working Group, Ireland and Northern Ireland’s Population Health Observatory (INIsPHO), Dublin

  4. Campbell IW (2001) Type 2 diabetes mellitus, ‘the silent killer’. Pract Diabetes Int 18(6):187–191. doi:10.1002/pdi.230

    Article  Google Scholar 

  5. Feher MD (2004) Diabetes: preventing coronary heart disease in a high risk group. Heart 90(Suppl 4):iv18–iv21. doi:10.1136/hrt.2004.037572

    Article  PubMed  Google Scholar 

  6. Laakso M (1999) Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937–942. doi:10.2337/diabetes.48.5.937

    Article  PubMed  CAS  Google Scholar 

  7. Curb JD, Pressel SL, Cutler JA, For the Systolic Hypertension in the Elderly Program Cooperative Research Group (SHEP) et al (1996) Effect of diuretic-based anti-hypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276:1886–1892. doi:10.1001/jama.276.23.1886

    Article  PubMed  CAS  Google Scholar 

  8. Staessen JA, Fagard R, Thijs L et al (1997) Morbidity and mortality in the placebo controlled European trial of isolated systolic hypertension (Syst-Eur) in the elderly. Lancet 350:757–764. doi:10.1016/S0140-6736(97)05381-6

    Article  PubMed  CAS  Google Scholar 

  9. Hansson L, Zanchetti A, Carruthers SG et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group. Lancet 351:1755–1762. doi:10.1016/S0140-6736(98)04311-6

    Article  PubMed  CAS  Google Scholar 

  10. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703–713

    Google Scholar 

  11. UK Prospective Diabetes Study Group (1998) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ 317:713–720

    Google Scholar 

  12. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the anti-hypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981–2997. doi:10.1001/jama.288.23.2981

    Article  Google Scholar 

  13. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389

    Google Scholar 

  14. Shepherd J, Cobbe SM, Ford I, West of Scotland Coronary Prevention Study Group (WOSCOPS) et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307. doi:10.1056/NEJM199511163332001

    Article  PubMed  CAS  Google Scholar 

  15. Sacks FR, Pfeffer MA, Moye LA, Cholesterol and Recurrent Events Trial Investigators (CARE) et al (1996) The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001–1009. doi:10.1056/NEJM199610033351401

    Article  PubMed  CAS  Google Scholar 

  16. Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22. doi:10.1016/S0140-6736(02)09327-3

    Article  Google Scholar 

  17. Sever PD, Dahlof B, Poulter NR et al (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:977–986. doi:10.1016/S0140-6736(03)12837-1

    Article  Google Scholar 

  18. Colhoun HM, Betteridge DJ, Durrington PN, CARDS Investigators et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696. doi:10.1016/S0140-6736(04)16895-5

    Article  PubMed  CAS  Google Scholar 

  19. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 287:2570–2581. doi:10.1001/jama.287.19.2570

    Article  PubMed  CAS  Google Scholar 

  20. Campos C (2007) Treating the whole patient for optimal management of type 2 diabetes: considerations for insulin therapy. South Med J 100(8):804–811

    PubMed  Google Scholar 

  21. Gaede P, Vedel P, Larsen N et al (2003) Multifactorial Intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393. doi:10.1056/NEJMoa021778

    Article  PubMed  Google Scholar 

  22. American Diabetes Association (2007) Standards of medical care in diabetes. Diabetes Care 30(Suppl. 1):S4–S41. doi:10.2337/dc07-S004

    Article  CAS  Google Scholar 

  23. Borzecki AM, Wong AT, Hickey EC et al (2003) Hypertension control; how well are we doing? Arch Intern Med 163:2705–2711. doi:10.1001/archinte.163.22.2705

    Article  PubMed  Google Scholar 

  24. Berlowitz DR, Ash AS, Hickey EC et al (1998) Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339:1957–1963. doi:10.1056/NEJM199812313392701

    Article  PubMed  CAS  Google Scholar 

  25. Berlowitz DR, Ash AS, Hickey EC et al (2003) Hypertension management in patients with diabetes; the need for more aggressive therapy. Diabetes Care 26:355–359. doi:10.2337/diacare.26.2.355

    Article  PubMed  Google Scholar 

  26. Sherlock M, Mylotte D, Mac Mahon J et al (2006) Lipid lowering targets are easier to attain than those for treatment of hypertension. Ir J Med Sci 175(4):36–41

    Article  PubMed  CAS  Google Scholar 

  27. Smith S, Bury G, O’Leary M, Shannon W, Tynan A, Staines A, Thompson C (2004) The North Dublin randomized controlled trial of structured diabetes shared care. Fam Pract 21:39–45. doi:10.1093/fampra/cmh109

    Article  PubMed  CAS  Google Scholar 

  28. Winocour PH (2002) Effective diabetes care: a need for realistic targets. BMJ 324:1577–1580. doi:10.1136/bmj.324.7353.1577

    Article  PubMed  Google Scholar 

  29. Denver EA, Barnard M, Woolfson RG, Earle KA (2003) Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care 26:2256–2260. doi:10.2337/diacare.26.8.2256

    Article  PubMed  Google Scholar 

  30. New JP, Mason JM, Freemantle N et al (2003) Specialist nurse-led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT). Diabetes Care 26:2250–2255. doi:10.2337/diacare.26.8.2250

    Article  PubMed  Google Scholar 

  31. American Diabetes Association, Position Statement (2001) Standards of medical care for patients with diabetes mellitus. Diabetes Care 24(Supp 1):S33–S43. doi:10.2337/diacare.24.1.33

    Google Scholar 

  32. American Diabetes Association (2002) Standards of medical care for patients with diabetes mellitus. Diabetes Care 25(supp 1):S33–S49. doi:10.2337/diacare.25.2007.S33

    Google Scholar 

  33. American Diabetes Association (1997) Aspirin therapy in diabetes (position statement). Diabetes Care 20:1772–1773

    Google Scholar 

  34. American Diabetes Association (2002) Management of dyslipidaemia in adults with diabetes (position statement). Diabetes Care 25:S74–S77. doi:10.2337/diacare.25.2007.S74

    Article  Google Scholar 

  35. Nathan DM (2002) Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 347(17):1342–1349. doi:10.1056/NEJMcp021106

    Article  PubMed  Google Scholar 

  36. LeRoith D, Smith DO (2005) Monitoring glycaemic control, the cornerstone of diabetes care. Clin Ther 27:1489–1499. doi:10.1016/j.clinthera.2005.10.010

    Article  PubMed  Google Scholar 

  37. Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes, a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29(8):1963–1972. doi:10.2337/dc06-9912

    Article  PubMed  Google Scholar 

  38. Nolan JJ, O’Halloran D, McKenna TJ et al (2006) The cost of treating type 2 diabetes (CODEIRE). Ir Med J 99(10):307–310

    PubMed  CAS  Google Scholar 

  39. Fontbonne A, Eschwege E, Cambien F et al (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease; mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300–304. doi:10.1007/BF00265546

    Article  PubMed  CAS  Google Scholar 

  40. Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria. Lancet 353:617–622. doi:10.1016/S0140-6736(98)07368-1

    Article  PubMed  CAS  Google Scholar 

  41. Colhoun HM, Dong W, Poulter NR (1998) Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 16:747–752. doi:10.1097/00004872-199816060-00005

    Article  PubMed  CAS  Google Scholar 

  42. Chobanian AV, Bakris GL, Black HR, National High Blood Pressure Education Program Coordinating Committee et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 289:2560–2571. doi:10.1001/jama.289.19.2560

    Article  PubMed  CAS  Google Scholar 

  43. Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913. doi:10.1016/S0140-6736(02)11911-8

    Article  PubMed  Google Scholar 

  44. Larme AC, Pugh JA (2001) Evidence-based guidelines meet the real world. Diabetes Care 24:1728–1733. doi:10.2337/diacare.24.10.1728

    Article  PubMed  CAS  Google Scholar 

  45. Kaplan NM (2001) Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence. Ann Intern Med 135:1079–1083

    PubMed  CAS  Google Scholar 

  46. IDF Clinical Guidelines Task Force (2005) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels, pp 35–38

  47. Taylor CB, Miller NH, Reilly KR et al (2003) Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes. Diabetes Care 26:1058–1062. doi:10.2337/diacare.26.4.1058

    Article  PubMed  Google Scholar 

  48. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986. doi:10.1056/NEJM199309303291401

    Article  Google Scholar 

  49. The UK Prospective Diabetes Study (UKPDS) Group (1998) Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317:720–726

    Google Scholar 

  50. The UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853. doi:10.1016/S0140-6736(98)07019-6

    Article  Google Scholar 

Download references

Acknowledgments

This research was support by a research grant from Bristol Myer Squibb (Ireland) and Pfizer Healthcare Ireland.

Author information

Authors and Affiliations

  1. Academic Department of Diabetes and Endocrinology, Beaumont Hospital/RCSI Medical School, Beaumont Road, Dublin 9, Ireland

    J. MacMahon Tone, A. Agha, M. Sherlock, F. Finucane & C. J. Thompson

  2. Department of Clinical Chemistry, Beaumont Hospital/RCSI Medical School, Dublin 9, Ireland

    W. Tormey

Authors
  1. J. MacMahon Tone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Agha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Sherlock
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Finucane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Tormey
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. J. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. J. Thompson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacMahon Tone, J., Agha, A., Sherlock, M. et al. An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care. Ir J Med Sci 178, 179–186 (2009). https://doi.org/10.1007/s11845-009-0316-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-009-0316-6

Keywords

Search

Navigation